[1]
|
A. Laupacis, P. Keown, N. Pus, et al., “A Study of the Quality of Life and Cost-Utility of Renal Transplant,” Kidney International, Vol. 50, No. 1, 1996, pp. 235-242.
doi:10.1038/ki.1996.307
|
[2]
|
B. F. Culleton, M. Walsh, S. W. Klarenbach, et al., “Effect of Frequent Nocturnal Hemodialysis vs Conventional Hemodialysis on Left Ventricular Mass and Quality of Life: A Randomized Controlled Trial,” Journal of the American Medical Association, Vol. 298, No. 11, 2007, pp. 1291-1299. doi:10.1001/jama.298.11.1291
|
[3]
|
P. A. McFarlane, A. M. Bayoumi, A. Pierratos and D. A. Redelmeier, “The Quality of Life and Cost Utility of Home Nocturnal and Conventional in-Center Hemodialysis,” Kidney International, Vol. 64, No. 3, 2003, pp. 1004-1011. doi:10.1046/j.1523-1755.2003.00157.x
|
[4]
|
M. V. Rocco, R. S. Lockridge, Jr, G. J. Beck, et al., “The Effects of Frequent Nocturnal Home Hemodialysis: The Frequent Hemodialysis Network Nocturnal Trial,” Kidney International, Vol. 80, No. 10, 2011, pp. 1080-1091.
doi:10.1038/ki.2011.213
|
[5]
|
M. John and K. Michael, “Starting a Home Hemodialysis Program,” Seminars in Dialysis, Vol. 20, No. 1, 2007, pp. 35-39. doi:10.1111/j.1525-139X.2007.00239.x
|
[6]
|
R. Mactier, N. Hoenich, C. Breen, “Renal Assocition Clinical Practice Guidelines 5th Edition 2009-2012,” Nephron Clinical Practice, Vol. 118, Suppl. 1, 2011, pp. 241-286.
|
[7]
|
S. Moe, T. Drueke, J. Cunningham, et al., “Definition, Evaluation, and Classification of Renal Osteodystrophy: A Position Statement from Kidney Disease: Improving Global Outcomes (KDIGO),” Kidney International, Vol. 69, No. 11, 2006, pp. 1945-1953.
doi:10.1038/sj.ki.5000414
|
[8]
|
W. G. Goodman, J. Goldin, B. D. Kuizon, et al., “Coronary Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis,” The New England Journal of Medicine, Vol. 342, No. 20, 2000, pp. 1478-1483.
doi:10.1056/NEJM200005183422003
|
[9]
|
W. Y. Qunibi, C. A. Nolan and J. C. Ayus, “Cardiovascular Calcification in Patients with End-Stage Renal Disease: A Century Old Phenomenon,” Kidney International, Vol. 62, Suppl. 82, 2002, pp. S73-S80.
doi:10.1046/j.1523-1755.62.s82.15.x
|
[10]
|
G. A. Block, P. S. Klassen, J. M. Lazarus, N. Ofsthun, E. G. Lowrie and G. M. Chertow, “Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis,” Journal of the American Society of Nephrology, Vol. 15, No. 8, 2004, pp. 2208-2218.
doi:10.1097/01.ASN.0000133041.27682.A2,
|
[11]
|
M. L. Melamed, J. A. Eustace, L. Plantinga, et al., “Changes in Serum Calcium, Phosphate, and PTH and the Risk of Death in Incident Dialysis Patients: Along Longitudinal Study,” Kidney International, Vol. 70, 2006, pp. 351-357. doi:10.1038/sj.ki.5001542
|
[12]
|
National Kidney Foundation, “K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease,” American Journal of Kidney Diseases, Vol. 42, Suppl. 3, 2003, pp. S1-S201.
doi:10.1016/S0272-6386(03)00553-5
|
[13]
|
K. Jindal, C. T. Chan, C. Deziel, et al., “Hemodialysis Clinical Practice Guidelines for the Canadian Society of Nephrology,” Journal of the American Society of Nephrology, Vol. 17, No. 3, 2006, pp. S1-S27.
|
[14]
|
Joint Specialty Committee on Renal Medicine of the Royal College of Physicians and the Renal Association, and the Royal College of General Practitioners, “Chronic Kidney Disease in Adults: UK Guidelines for Identification, Management and Referral,” Royal College of Physicians, London, 2006.
|
[15]
|
G. Elder, R. Faull, P. Branley and C. Hawley, “Management of Bone Disease, Calcium, Phosphate and Parathyroid Hormone,” Nephrology, Vol. 11, Suppl. 1, 2006, pp. S230-S261. doi:10.1111/j.1440-1797.2006.00508.x
|
[16]
|
CKD-MBD Work Group, “KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD),” Kidney International, Vol. 113, 2009, pp. S1-130.
|
[17]
|
J. B Cannata-Andía, T. B. Drueke, J. Cunningham, et al., “Clinical Algorithms on Renal Osteodystrophy,” Nephrology Dialysis Transplantation, Vol. 15, Suppl. 5, 2000, pp. S39-S57.
|
[18]
|
F. Tentori, M. J. Blayney, J. M. Albert, et al., “Mortality Risk for Dialysis Patients with Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS),” American Journal of Kidney Diseases, Vol. 52, No. 3, 2008, pp. 519-553.
doi:10.1053/j.ajkd.2008.03.020
|
[19]
|
G. A. Block, P. S. Klassen, J. M. Lazarus, N. Ofsthun, E. G. Lowrie and G. M. Chertow, “Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis,” Journal of the American Society of Nephrology, Vol. 15, No. 8, 2004, 2208-2218.
doi:10.1097/01.ASN.0000133041.27682.A2
|
[20]
|
R. M. Lindsay, F. Alhejaili, G. Nesrallah, et al., “Calcium and Phosphate Balance with Quotidian Hemodialysis,” American Journal of Kidney Diseases, Vol. 42, No. 1, 2003, pp. S24-S29. doi:10.1016/S0272-6386(03)00534-1
|
[21]
|
N. Toussaint, J. Boddington, R. Simmonds, C. Waldron, C. Soerville and J. Agar, “Calcium Phosphate Metabolism and Bone Mineral Density with Nocturnal Hemodialysis,” HHemodialysis International, Vol. 10, No. 3, 2006, pp. 280-286.
doi:10.1111/j.1542-4758.2006.00109.x
|